|
|
| | LDC7559 Basic information |
| Product Name: | LDC7559 | | Synonyms: | Acetamide, N-[2-(2-methoxyphenyl)-4H,10H-pyrazolo[5,1-c][1,4]benzoxazepin-7-yl]-;LDC7559;Inhibitor,Pyroptosis,LDC7559,inhibit,LDC 7559,LDC-7559 | | CAS: | 2407782-01-6 | | MF: | C20H19N3O3 | | MW: | 349.38 | | EINECS: | | | Product Categories: | | | Mol File: | 2407782-01-6.mol |  |
| | LDC7559 Chemical Properties |
| Boiling point | 596.3±50.0 °C(Predicted) | | density | 1.29±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO : ≥ 125 mg/mL (357.78 mM) | | pka | 14.44±0.20(Predicted) | | form | Solid | | color | White to light yellow |
| | LDC7559 Usage And Synthesis |
| Description | LDC7559 is a gasdermin D (GSDMD) inhibitor via blocking neutrophil extracellular trap (NET) in the late stages. | | in vitro | LDC7559 (1 and 5 μM) inhibits IL-1β release upon inflammasome activation, and significantly blocks the lethal effect of both human and murine GSDMD NT domains transfected into HEK293T cells.
LDC7559 functions directly through blocking the activity of the GSDMD NT domain, rather than interfering with the activation and cleavage process. |
| | LDC7559 Preparation Products And Raw materials |
|